concentrations of primary antibodies are basically lower than with other
detection systems. We strongly recommend optimizing concentration of primary
antibody when switching over to AmpliStain™. This is worth effort
since in the long run can afford significant cost saving through lower
consumption of primary antibodies, in particular precious and expensive
antibodies, resulting in more economical IHC protocols.
On the whole, Ready to Use RESERVE™ format in combination with UDBS offers
rational and cost effective work approach - in what concerns both primary
antibody and detection reagent consumption across optimal sensitivities with
different IHC targets.
StrongZyme™ and Ready to Use RESERVE™ are Trademarks of SDT.